Health Canada, Novavax and COVID-19 vaccine
Health Canada approves Novavax's updated COVID-19 vaccine for fall
Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up.
Health Canada approves Moderna’s COVID-19 vaccine targeting latest variant
The KP.3 variant of SARS-CoV-2 is dominating in Canada right now, accounting for the majority of the COVID-19 cases in the country.
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians
Moderna's updated COVID-19 vaccine for 2024-25 approved in Canada
Health Canada authorized Moderna's updated COVID-19 vaccine on Tuesday to roll out in fall and winter immunization campaigns.
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last month, the U.S. Food and Drug Administration also gave approval for the vaccine, as well as updated shots from Pfizer ( PFE) and BioNTech ( BNTX ).
Moderna Shares Rise on Canada Government Approval of Updated Covid-19 Vaccine
Shares of Moderna rose after the company said that the government of Canada authorized its updated Covid-19 vaccine, joining the U.S. in the approval. The stock was up 4.5% at $72.28 in Tuesday afternoon trading, becoming the best performing stock of the S&P 500 and Nasdaq 100. The stock has, however, dropped 26% since the beginning of the year.
Health Canada approves updated Novavax COVID-19 vaccine
Health Canada authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Thursday. The protein-based vaccine, called Nuvaxovid, targets the JN.1 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant, the agency said in an online update.
Health Canada approves updated Moderna COVID-19 vaccine
Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday. The mRNA vaccine, called Spikevax, has been reformulated to target the KP.
Bay Area health officials encourage residents to get updates COVID vaccines
Read more: <a href=" Shohei Ohtani becomes the first major league player to exceed 50 homers and 50 steals in a season What to Do With Old Cell Phones (Because You Can’t Throw Them Away) House members bypass Mike Johnson a second time to force Social Security vote What’s on TV tonight: James Herriot returns in All Creatures Great and Small Researchers Study Life After Death — And It Gets Weirder 12 States Trying To Ban Gas Powered Cars (Even Though Voters Want Them) I’ve been retired in Mexico for 6 years—it's a luxury that ‘presents a new,
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
Canada to donate 'up to 200,000' doses of mpox vaccine
TORONTO, Sept 11 (Reuters) - Canada is donating "up to 200,000" doses of mpox vaccine, a government spokesperson said on ...
canadianinquirer13d
Provinces told to destroy existing COVID-19 vaccines ahead of arrival of updated shots
By Amina Zafar, CBC News, RCI Ontario expects updated vaccine to be rolled out in October Health Canada has directed all ...
U.S. News & World Report9d
Canada to Donate 'Up to 200,000' Doses of Mpox Vaccine
Canada to Donate 'Up to 200,000' Doses of Mpox Vaccine By Anna Mehler Paperny TORONTO (Reuters) - Canada is donating "up to 200,000" doses of mpox vaccine, a government spokesperson said on ...
Monkey Pox vaccine: Bavarian Nordic’s smallpox vaccine found 58% effective after one dose
The MVA-BN vaccine, designed for smallpox, has shown 58% effectiveness against mpox after a single dose in a Canadian study.